Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations
NCT02446691
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
128
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL:
MenACWY
Sponsor
GlaxoSmithKline